TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/19/17 18:14 | 6/15/17 | NBRV | Nabriva Therapeutics AG | C4 | Health | Drug | Pharmaceutical Preparations | Talbot George Harrison | PA | D | S.m | -16 | 93.18 | 0 | 0 | -5 | 3 | D | |||||||||||||||
6/1/17 20:49 | 5/30/17 | NBRV | Nabriva Therapeutics AG | C4 | Health | Drug | Pharmaceutical Preparations | Talbot George Harrison | PA | D | S | -21 | 101.26 | 0 | 0 | -6 | 3 | D | |||||||||||||||
5/25/17 20:58 | 5/23/17 | NBRV | Nabriva Therapeutics AG | C4 | Health | Drug | Pharmaceutical Preparations | Talbot George Harrison | PA | D | S.m | -33 | 100.57 | 0 | 0 | -8 | 4 | D | |||||||||||||||
5/17/17 19:01 | 5/15/17 | NBRV | Nabriva Therapeutics AG | C4 | Health | Drug | Pharmaceutical Preparations | Talbot George Harrison | PA | D | S.dm | -20 | 102.44 | 0 | 0 | -5 | 4 | D | 15 | 123 | 2 | -19 | -11 | -9 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |